New York State Common Retirement Fund’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Hold
28,000
﹤0.01% 1553
2025
Q4
$1.47M Buy
28,000
+1,800
+7% +$108K ﹤0.01% 1526
2025
Q3
$1.7M Hold
26,200
﹤0.01% 1491
2025
Q2
$1.27M Buy
26,200
+24,972
+2,034% +$966K ﹤0.01% 1578
2025
Q1
$41.8K Hold
1,228
﹤0.01% 2839
2024
Q4
$48.3K Hold
1,228
﹤0.01% 2863
2024
Q3
$57.7K Hold
1,228
﹤0.01% 2814
2024
Q2
$66.3K Hold
1,228
﹤0.01% 3016
2024
Q1
$83.7K Hold
1,228
﹤0.01% 2817
2023
Q4
$76.9K Buy
+1,228
New +$67.9K ﹤0.01% 2845
2022
Q2
Sell
-5,934
Closed -$372K 3484
2022
Q1
$372K Buy
5,934
+2,000
+51% +$126K ﹤0.01% 2536
2021
Q4
$298K Buy
3,934
+150
+4% +$13.1K ﹤0.01% 2711
2021
Q3
$424K Hold
3,784
﹤0.01% 2551
2021
Q2
$613K Sell
3,784
-1,050
-22% -$128K ﹤0.01% 2486
2021
Q1
$589K Sell
4,834
-3,010
-38% -$454K ﹤0.01% 2373
2020
Q4
$1.2M Buy
7,844
+5,210
+198% +$616K ﹤0.01% 1959
2020
Q3
$220K Hold
2,634
﹤0.01% 2604
2020
Q2
$194K Hold
2,634
﹤0.01% 2653
2020
Q1
$112K Sell
2,634
-3,011
-53% -$155K ﹤0.01% 2715
2019
Q4
$344K Buy
5,645
+3,061
+118% +$167K ﹤0.01% 2470
2019
Q3
$106K Buy
2,584
+450
+21% +$21.5K ﹤0.01% 3012
2019
Q2
$101K Sell
2,134
-200
-9% -$7.99K ﹤0.01% 3102
2019
Q1
$83K Sell
2,334
-150
-6% -$5.19K ﹤0.01% 2997
2018
Q4
$71K Sell
2,484
-4,619
-65% -$161K ﹤0.01% 3043
2018
Q3
$315K Sell
7,103
-2,488
-26% -$130K ﹤0.01% 2628
2018
Q2
$564K Sell
9,591
-100
-1% -$5.7K ﹤0.01% 2398
2018
Q1
$443K Buy
9,691
+1,107
+13% +$45.7K ﹤0.01% 2409
2017
Q4
$202K Sell
8,584
-10,692
-55% -$203K ﹤0.01% 2754
2017
Q3
$344K Buy
+19,276
New +$350K ﹤0.01% 2536

Other funds holding CRSP